NAFDAC says there’s a fake injection in circulation
The National Agency for Food and Drugs Administration and Control, NAFDAC, has notified the public, particularly healthcare providers, to one batch of counterfeit Meronem 1g Injection being purchased in the country.
The notification of this product is contained in a public alert No. 036/2023, signed by the Director-General of the agency, Prof. Mojisola Adeyeye, on Tuesday, in Abuja.
Adeyeye said that the agency was equally notified about the injection by the Marketing Authorisation Holder Pfizer, who reported the incident, as received through a patient notification platform.
The NAFDAC boss said Pfizer reported that the vial content did not dissolve when reconstituted for use and that further visual inspection of the pack was observed.
It was also reported that the crimp code did not match the code reported on the production documentation batch of 2A21F11, which is the semi-finished batch used for 4A21I17.
She said that the production process did not meet Pfizer’s specifications.
“The vial label compares favourably to the purported artwork version.
“Meronem (Meropenem trihydrate injection) is an antibiotic used to treat skin and abdominal (stomach area) infections caused by bacteria and meningitis (infection of the membranes that surround the brain and spinal cord) in adults and children 3 months of age and older.
“The administration of the counterfeit product will pose a high risk to patients as the quality and safety are not guaranteed,” Adeyeye said.
The NAFDAC boss, however, said that healthcare providers and patients were advised to obtain all medical products from authorised/licensed suppliers.
The post NAFDAC says there’s a fake injection in circulation appeared first on Ladun Liadi’s News.
PROMOTE YOUR | MUSIC| VIDEO | COMEDY SKIT | MIXTAPES HERE ON CONNECTNAIJA CALL/WHATSAPP : +2348122390211